MedTrace Logo

Autoantibody Specificity and Response to IVIG in ITP

NCT01666795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 672

Last updated 2016-04-20

No results posted yet for this study

Summary

The objective of this human study was to evaluate the association between the specificity of anti-platelet autoantibodies and response to IVIG treatment.

Conditions

  • Immune Thrombocytopenia (ITP)

Sponsors & Collaborators

  • Second Affiliated Hospital of Medical College Shandong University

    collaborator OTHER

  • Jinan Military General Hospital

    collaborator OTHER

  • Shandong University of Traditional Chinese Medicine

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Shandong University

    lead OTHER

Principal Investigators

  • Ming Hou, MD · Qilu Hospital, Shandong University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2013-01-31
Completion
2014-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01666795 on ClinicalTrials.gov